Clinical trials
Completed Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
366 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 6 |
| 2003 | 17 |
| 2004 | 7 |
| 2005 | 12 |
| 2006 | 18 |
| 2007 | 13 |
| 2008 | 12 |
| 2009 | 23 |
| 2010 | 23 |
| 2011 | 21 |
| 2012 | 18 |
| 2013 | 24 |
| 2014 | 15 |
| 2015 | 26 |
| 2016 | 13 |
| 2017 | 23 |
| 2018 | 14 |
| 2019 | 11 |
| 2020 | 15 |
| 2021 | 18 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 7 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 366 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 61 |
| Merck KGaA, Darmstadt, Germany | 22 |
| Novartis Pharmaceuticals | 19 |
| Bayer | 15 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 8 |
| GlaxoSmithKline | 7 |
| Johns Hopkins University | 7 |
| EMD Serono | 6 |
| Genzyme, a Sanofi Company | 6 |
| Tanabe Pharma Corporation | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 366 |
| Multiple Sclerosis | 179 |
| Multiple Sclerosis, Chronic Progressive | 35 |
| Fatigue | 20 |
| Demyelinating Diseases | 10 |
| Autoimmune Diseases | 7 |
| Nervous System Diseases | 7 |
| Recurrence | 7 |
| Cognitive Dysfunction | 6 |
| Immune System Diseases | 4 |
Trials
Showing 1 to 25 of 366. Each trial links to its page on Pharma Observatory.
266 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.